These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9119714)
41. Quantification of analgesic use in children with sickle cell disease. Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L Clin J Pain; 2007 Jan; 23(1):8-14. PubMed ID: 17277639 [TBL] [Abstract][Full Text] [Related]
42. Trends in complete blood count values during acute painful episodes in children with sickle cell disease. Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L J Pediatr Oncol Nurs; 2005; 22(3):152-9. PubMed ID: 15855476 [TBL] [Abstract][Full Text] [Related]
43. Assessment of sickle cell pain in children and young adults using the adolescent pediatric pain tool. Franck LS; Treadwell M; Jacob E; Vichinsky E J Pain Symptom Manage; 2002 Feb; 23(2):114-20. PubMed ID: 11844631 [TBL] [Abstract][Full Text] [Related]
44. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study. Nottage KA; Hankins JS; Faughnan LG; James DM; Richardson J; Christensen R; Kang G; Smeltzer M; Cancio MI; Wang WC; Anghelescu DL Clin Trials; 2016 Aug; 13(4):409-16. PubMed ID: 27000103 [TBL] [Abstract][Full Text] [Related]
45. Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. Stallworth JR; Jerrell JM; Tripathi A Am J Hematol; 2010 Oct; 85(10):795-7. PubMed ID: 20645429 [TBL] [Abstract][Full Text] [Related]
46. Home management of sickle cell-related pain in children and adolescents: natural history and impact on school attendance. Shapiro BS; Dinges DF; Orne EC; Bauer N; Reilly LB; Whitehouse WG; Ohene-Frempong K; Orne MT Pain; 1995 Apr; 61(1):139-144. PubMed ID: 7644237 [TBL] [Abstract][Full Text] [Related]
47. Magnesium for treating sickle cell disease. Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011358. PubMed ID: 28409830 [TBL] [Abstract][Full Text] [Related]
48. Pain management at home in children with cancer: a daily diary study. Fortier MA; Wahi A; Bruce C; Maurer EL; Stevenson R Pediatr Blood Cancer; 2014 Jun; 61(6):1029-33. PubMed ID: 24376073 [TBL] [Abstract][Full Text] [Related]
49. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis. Yaster M; Tobin JR; Billett C; Casella JF; Dover G Pediatrics; 1994 Feb; 93(2):310-5. PubMed ID: 8121746 [TBL] [Abstract][Full Text] [Related]
50. Impact of individualized pain plan on the emergency management of children with sickle cell disease. Krishnamurti L; Smith-Packard B; Gupta A; Campbell M; Gunawardena S; Saladino R Pediatr Blood Cancer; 2014 Oct; 61(10):1747-53. PubMed ID: 24962217 [TBL] [Abstract][Full Text] [Related]
51. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease. Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790 [TBL] [Abstract][Full Text] [Related]
52. Clinical profile and home management of sickle cell-related pain: the Enugu (Nigeria) experience. Ikefuna AN; Emodi IJ; Ocheni S Pediatr Hematol Oncol; 2009; 26(5):309-12. PubMed ID: 19579076 [TBL] [Abstract][Full Text] [Related]
53. Efficacy and Tolerance of Lidocaine 5% Patches in Neuropathic Pain and Pain Related to Vaso-occlusive Sickle Cell Crises in Children: A Prospective Multicenter Clinical Study. Rousseau V; Morelle M; Arriuberge C; Darnis S; Chabaud S; Launay V; Thouvenin S; Roumenoff-Turcant F; Metzger S; Tourniaire B; Marec-Berard P Pain Pract; 2018 Jul; 18(6):788-797. PubMed ID: 29266772 [TBL] [Abstract][Full Text] [Related]
55. Randomised trial of oral morphine for painful episodes of sickle-cell disease in children. Jacobson SJ; Kopecky EA; Joshi P; Babul N Lancet; 1997 Nov; 350(9088):1358-61. PubMed ID: 9365450 [TBL] [Abstract][Full Text] [Related]
56. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department. García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592 [TBL] [Abstract][Full Text] [Related]
57. Self-care of men with priapism and sickle cell disease. Costa DO; Araújo FA; Xavier ASG; Araújo LDS; Silva UBD; Santos EA; Ferreira SL Rev Bras Enferm; 2018; 71(5):2418-2424. PubMed ID: 30304171 [TBL] [Abstract][Full Text] [Related]
58. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy. Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148 [TBL] [Abstract][Full Text] [Related]
59. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome. Buchanan ID; Woodward M; Reed GW Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170 [TBL] [Abstract][Full Text] [Related]
60. Initial Evaluation of the Pediatric PROMIS® Health Domains in Children and Adolescents With Sickle Cell Disease. Dampier C; Barry V; Gross HE; Lui Y; Thornburg CD; DeWalt DA; Reeve BB Pediatr Blood Cancer; 2016 Jun; 63(6):1031-7. PubMed ID: 26895143 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]